Airway host-microbiome interactions in chronic obstructive pulmonary disease

Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, alo...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 20; no. 1; pp. 113 - 14
Main Authors Wang, Zhang, Maschera, Barbara, Lea, Simon, Kolsum, Umme, Michalovich, David, Van Horn, Stephanie, Traini, Christopher, Brown, James R., Hessel, Edith M., Singh, Dave
Format Journal Article
LanguageEnglish
Published London BioMed Central 06.06.2019
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1465-993X
1465-9921
1465-993X
DOI10.1186/s12931-019-1085-z

Cover

Abstract Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus , host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus , interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella -associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
AbstractList Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).BACKGROUNDLittle is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients.METHODSWe performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients.Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations.RESULTSDysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations.Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.CONCLUSIONSOur study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Keywords: Chronic obstructive pulmonary disease, COPD, Microbiome, Exacerbations, Clinical study, Transcriptome, Proteome, Healthy, Smokers, Next-generation sequencing technologies
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
Abstract Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus , host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus , interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella -associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.
ArticleNumber 113
Audience Academic
Author Maschera, Barbara
Brown, James R.
Michalovich, David
Lea, Simon
Kolsum, Umme
Hessel, Edith M.
Wang, Zhang
Van Horn, Stephanie
Traini, Christopher
Singh, Dave
Author_xml – sequence: 1
  givenname: Zhang
  surname: Wang
  fullname: Wang, Zhang
  organization: Computational Biology, Human Genetics, Research and Development (R&D), GlaxoSmithKline (GSK), Present Address: School of Life Sciences, South China Normal University
– sequence: 2
  givenname: Barbara
  surname: Maschera
  fullname: Maschera, Barbara
  organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK
– sequence: 3
  givenname: Simon
  surname: Lea
  fullname: Lea, Simon
  organization: University of Manchester and University Hospital of South Manchester
– sequence: 4
  givenname: Umme
  surname: Kolsum
  fullname: Kolsum, Umme
  organization: University of Manchester and University Hospital of South Manchester
– sequence: 5
  givenname: David
  surname: Michalovich
  fullname: Michalovich, David
  organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK
– sequence: 6
  givenname: Stephanie
  surname: Van Horn
  fullname: Van Horn, Stephanie
  organization: Functional Genomics, Medicinal Science and Technology, R&D, GSK
– sequence: 7
  givenname: Christopher
  surname: Traini
  fullname: Traini, Christopher
  organization: Functional Genomics, Medicinal Science and Technology, R&D, GSK
– sequence: 8
  givenname: James R.
  orcidid: 0000-0002-9368-627X
  surname: Brown
  fullname: Brown, James R.
  email: James.R.Brown@gsk.com
  organization: Computational Biology, Human Genetics, Research and Development (R&D), GlaxoSmithKline (GSK)
– sequence: 9
  givenname: Edith M.
  surname: Hessel
  fullname: Hessel, Edith M.
  organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK
– sequence: 10
  givenname: Dave
  surname: Singh
  fullname: Singh, Dave
  organization: University of Manchester and University Hospital of South Manchester
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31170986$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQjVAR_YAfwAVF4sIlxZ9xfEFaVXxUWokLSNwsx5nsepXYi50Utb-eWbYs3QqQZdkev_c8M37nxUmIAYriJSWXlDb120yZ5rQiVFeUNLK6e1KcUVHLSmv-7eTB_rQ4z3lDCFWNks-KU06pIrqpz4rlwqcf9rZcxzxVo3cptj6OUPowQbJu8jFkPJRunWLwroxtntKM8Rsot_MwxmDTbdn5DDbD8-Jpb4cML-7Xi-Lrh_dfrj5Vy88fr68Wy8rVhE-V44wLi1PrRoq2o7IT4BiVugNNa8k1dFK3UoDmDe871YLtO90pJAoqKL8orve6XbQbs01-xCRMtN78CsS0MjZN3g1gnKS25k0DtukFawGlCPZOcMEtaXuFWu_2Wtu5HaFzEKZkhyPR45vg12YVb0wtpVSiQYE39wIpfp8hT2b02cEw2ABxzoZxTpmsidrl_foRdBPnFLBVhjHBFOEcf-uAWlkswIc-4rtuJ2oWUhPFmdYMUZd_QeHoAL8RfdJ7jB8RXj0s9FDhby8ggO4BaIKcE_QHCCVm5zez95tBv5md38wdctQjjvOT3bkGs_HDf5lsz8z4SlhB-tOLf5N-AvYY6YA
CitedBy_id crossref_primary_10_1080_19490976_2022_2156254
crossref_primary_10_1097_MCP_0000000000000850
crossref_primary_10_2147_COPD_S357491
crossref_primary_10_1080_1040841X_2020_1830748
crossref_primary_10_1016_j_micpath_2023_106335
crossref_primary_10_2147_COPD_S371958
crossref_primary_10_3389_fmicb_2020_01758
crossref_primary_10_1111_cei_13638
crossref_primary_10_1111_jcmm_16206
crossref_primary_10_3390_cells11091416
crossref_primary_10_3390_medsci8010006
crossref_primary_10_1136_bmj_2021_065871
crossref_primary_10_1007_s12275_024_00167_4
crossref_primary_10_2217_bmm_2021_0653
crossref_primary_10_1093_jleuko_qiae153
crossref_primary_10_3389_fmicb_2024_1451160
crossref_primary_10_1042_CS20220175
crossref_primary_10_3389_fcimb_2023_1161203
crossref_primary_10_1016_j_jaci_2023_10_001
crossref_primary_10_1038_s41591_023_02424_2
crossref_primary_10_3390_biomedicines9101337
crossref_primary_10_3390_jpm13050804
crossref_primary_10_1186_s12879_020_05313_y
crossref_primary_10_3389_fimmu_2024_1407439
crossref_primary_10_3390_biomedicines10051110
crossref_primary_10_1183_16000617_0084_2023
crossref_primary_10_1016_j_rmed_2020_106092
crossref_primary_10_1038_s41598_023_32901_0
crossref_primary_10_3390_ijms24032955
crossref_primary_10_3390_ijms221910872
crossref_primary_10_1111_imm_13848
crossref_primary_10_1093_jac_dkaa557
crossref_primary_10_1186_s12931_025_03113_z
crossref_primary_10_1186_s12950_022_00308_9
crossref_primary_10_1186_s12931_022_02069_8
crossref_primary_10_23749_mdl_v111i6_10947
crossref_primary_10_3389_fphar_2022_1020133
crossref_primary_10_1016_j_micpath_2023_106062
crossref_primary_10_3389_fmolb_2022_839259
crossref_primary_10_1172_JCI150473
crossref_primary_10_1016_S2666_5247_21_00035_5
crossref_primary_10_1099_mgen_0_000754
crossref_primary_10_1002_INMD_20230023
crossref_primary_10_1016_j_antiviral_2025_106076
crossref_primary_10_12677_ACM_2020_106135
crossref_primary_10_1097_MCP_0000000000000834
crossref_primary_10_1111_apm_13386
crossref_primary_10_1016_j_heliyon_2024_e24775
crossref_primary_10_1183_23120541_00044_2022
crossref_primary_10_3390_jcm10132889
crossref_primary_10_1038_s41522_021_00185_9
crossref_primary_10_2147_COPD_S337181
crossref_primary_10_1038_s41467_020_19701_0
crossref_primary_10_1093_jambio_lxae089
crossref_primary_10_3390_ijms25158223
crossref_primary_10_1155_2021_9278441
crossref_primary_10_1002_imt2_33
crossref_primary_10_1007_s12016_022_08928_y
crossref_primary_10_1038_s41598_021_99238_4
crossref_primary_10_3390_ijms25158467
crossref_primary_10_1186_s12931_024_02973_1
crossref_primary_10_31083_j_fbs1403023
crossref_primary_10_1183_16000617_0053_2024
crossref_primary_10_12688_f1000research_132220_4
crossref_primary_10_3389_fmicb_2022_1085079
crossref_primary_10_1016_j_ijid_2024_107274
crossref_primary_10_12688_f1000research_132220_3
crossref_primary_10_12688_f1000research_132220_2
crossref_primary_10_12688_f1000research_132220_1
crossref_primary_10_1099_mgen_0_000485
crossref_primary_10_1183_16000617_0241_2021
crossref_primary_10_3389_fcimb_2024_1386201
crossref_primary_10_1016_j_csbj_2023_10_016
crossref_primary_10_1080_14789450_2023_2265062
crossref_primary_10_3390_cells11010002
crossref_primary_10_1016_j_micres_2022_127244
crossref_primary_10_1002_cdt3_66
crossref_primary_10_4046_trd_2020_0026
crossref_primary_10_1093_jac_dkae335
crossref_primary_10_1186_s12931_021_01722_y
crossref_primary_10_1183_20734735_0161_2021
crossref_primary_10_1080_17476348_2024_2355155
crossref_primary_10_1111_crj_13294
crossref_primary_10_1183_23120541_00168_2020
crossref_primary_10_1186_s12931_020_01552_4
crossref_primary_10_3389_fcimb_2024_1379831
crossref_primary_10_3390_ijms23105692
crossref_primary_10_4168_aair_2021_13_4_589
crossref_primary_10_1136_thorax_2021_217923
crossref_primary_10_1183_23120541_00595_2023
crossref_primary_10_3389_fbioe_2025_1524013
crossref_primary_10_1016_j_bioflm_2022_100096
Cites_doi 10.1164/ajrccm.152.4.7551388
10.1089/omi.2009.0100
10.1378/chest.14-0764
10.7326/0003-4819-106-2-196
10.1186/s12915-014-0087-z
10.1186/s40169-015-0068-z
10.1371/journal.pone.0016384
10.1186/1741-7015-11-181
10.1093/nar/gkv007
10.1111/j.2517-6161.1995.tb02031.x
10.1080/15216540600756004
10.1016/j.immuni.2018.04.022
10.1164/ajrccm.157.5.9711044
10.1038/nmeth.f.303
10.1073/pnas.1322269111
10.1378/chest.116.1.40
10.1371/journal.pone.0047305
10.1016/S0140-6736(14)61136-3
10.1159/000330667
10.1038/mi.2017.75
10.1007/s10096-013-2044-0
10.1186/1471-2105-13-52
10.1136/thoraxjnl-2017-210408
10.1093/gerona/glu121
10.1073/pnas.0506580102
10.1152/ajplung.00449.2007
10.1136/thoraxjnl-2017-210741
10.1164/rccm.201111-2075OC
10.1378/chest.117.5_suppl_2.398S
10.1371/journal.pone.0079353
10.1371/journal.pone.0008578
10.1164/rccm.201302-0341OC
10.1164/rccm.201502-0223OC
10.1073/pnas.1507719112
10.1093/bioinformatics/btp616
10.1038/ng0506-500
10.1128/CMR.14.2.336-363.2001
10.1183/13993003.01406-2015
10.1186/1559-0275-11-32
10.1128/JCM.00035-14
10.1378/chest.108.2_Supplement.43S
10.1164/rccm.201607-1408OC
10.1186/s13059-015-0637-x
10.1186/1465-9921-14-85
10.1371/journal.pone.0068302
10.1371/journal.pone.0024457
10.18637/jss.v067.i01
10.3390/ijerph6010209
10.1164/rccm.201104-0597OC
ContentType Journal Article
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12931-019-1085-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals (WRLC)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic



MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
EndPage 14
ExternalDocumentID oai_doaj_org_article_c51a6388ea8f42bebea01184343a0bf7
PMC6555748
A590732992
31170986
10_1186_s12931_019_1085_z
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
FRP
M~E
NPM
PMFND
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c603t-c3234a23499854bd15d4ec2159de916539ed59b54e9383fd7beafd9d7c3241413
IEDL.DBID 7X7
ISSN 1465-993X
1465-9921
IngestDate Wed Aug 27 01:30:59 EDT 2025
Thu Aug 21 17:55:49 EDT 2025
Thu Sep 04 17:44:49 EDT 2025
Sat Aug 23 14:58:15 EDT 2025
Tue Jun 17 21:06:51 EDT 2025
Tue Jun 10 20:42:29 EDT 2025
Thu Jan 02 22:59:50 EST 2025
Thu Apr 24 22:57:22 EDT 2025
Tue Jul 01 02:43:14 EDT 2025
Sat Sep 06 07:28:58 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Smokers
Transcriptome
Exacerbations
Proteome
Chronic obstructive pulmonary disease
Next-generation sequencing technologies
Healthy
COPD
Microbiome
Clinical study
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-c3234a23499854bd15d4ec2159de916539ed59b54e9383fd7beafd9d7c3241413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9368-627X
OpenAccessLink https://www.proquest.com/docview/2242703399?pq-origsite=%requestingapplication%
PMID 31170986
PQID 2242703399
PQPubID 42864
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_c51a6388ea8f42bebea01184343a0bf7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6555748
proquest_miscellaneous_2331256071
proquest_journals_2242703399
gale_infotracmisc_A590732992
gale_infotracacademiconefile_A590732992
pubmed_primary_31170986
crossref_primary_10_1186_s12931_019_1085_z
crossref_citationtrail_10_1186_s12931_019_1085_z
springer_journals_10_1186_s12931_019_1085_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-06-06
PublicationDateYYYYMMDD 2019-06-06
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-06-06
  day: 06
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Respiratory research
PublicationTitleAbbrev Respir Res
PublicationTitleAlternate Respir Res
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References T Zakharkina (1085_CR39) 2013; 8
M Reich (1085_CR34) 2006; 38
L Millares (1085_CR10) 2014; 33
RP Dickson (1085_CR13) 2014; 384
R Rodriguez-Roisin (1085_CR19) 2000; 117
SA Shetty (1085_CR47) 2013; 8
GP DeMuri (1085_CR46) 2017
B Brindefalk (1085_CR32) 2011; 6
A Subramanian (1085_CR33) 2005; 102
PT King (1085_CR43) 2015; 4
Y Hathout (1085_CR26) 2015; 112
S Sethi (1085_CR45) 2001; 14
David Mayhew (1085_CR12) 2018; 73
MA Sze (1085_CR7) 2012; 185
A Trompette (1085_CR49) 2018; 48
DMM Bates (1085_CR30) 2015; 67
M Mofarrahi (1085_CR40) 2008; 294
NR Anthonisen (1085_CR18) 1987; 106
JR Erb-Downward (1085_CR37) 2011; 6
BL Barker (1085_CR42) 2015; 147
PV Chang (1085_CR48) 2014; 111
Zhang Wang (1085_CR11) 2017; 73
PL Molyneaux (1085_CR36) 2013; 188
X Wang (1085_CR23) 2012; 13
JA Wedzicha (1085_CR53) 2013; 11
MA Sze (1085_CR14) 2015; 192
KA BPaCR (1085_CR31) 2014
YJ Huang (1085_CR8) 2014; 52
MD Robinson (1085_CR27) 2010; 26
YJ Huang (1085_CR38) 2010; 14
HF Lu (1085_CR51) 2017; 6
M Bafadhel (1085_CR20) 2012; 83
JG Caporaso (1085_CR21) 2010; 7
AI Ivanov (1085_CR41) 2006; 58
M Bafadhel (1085_CR55) 2011; 184
ME Ritchie (1085_CR28) 2015; 43
AA Pragman (1085_CR6) 2012; 7
MR Mehan (1085_CR25) 2014; 11
Z Wang (1085_CR54) 2016; 47
SJ Salter (1085_CR22) 2014; 12
Z Wang (1085_CR9) 2016
E Klaile (1085_CR44) 2013; 14
M Hilty (1085_CR5) 2010; 5
C Menni (1085_CR24) 2015; 70
E Monso (1085_CR3) 1995; 152
International Conference on (1085_CR17) 2001; 47
R Laniado-Laborin (1085_CR52) 2009; 6
M Miravitlles (1085_CR2) 1999; 116
XC Morgan (1085_CR29) 2015; 16
PL Molyneaux (1085_CR15) 2017; 195
N Soler (1085_CR4) 1998; 157
P Ball (1085_CR1) 1995; 108
General Assembly of the World Medical A (1085_CR16) 2014; 81
Y Benjamini (1085_CR35) 1995; 57
A Cait (1085_CR50) 2018; 11
References_xml – volume: 152
  start-page: 1316
  issue: 4 Pt 1
  year: 1995
  ident: 1085_CR3
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.152.4.7551388
– volume: 14
  start-page: 9
  issue: 1
  year: 2010
  ident: 1085_CR38
  publication-title: Omics
  doi: 10.1089/omi.2009.0100
– volume: 147
  start-page: 46
  issue: 1
  year: 2015
  ident: 1085_CR42
  publication-title: Chest
  doi: 10.1378/chest.14-0764
– volume: 106
  start-page: 196
  issue: 2
  year: 1987
  ident: 1085_CR18
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-106-2-196
– volume: 12
  start-page: 87
  year: 2014
  ident: 1085_CR22
  publication-title: BMC Biol
  doi: 10.1186/s12915-014-0087-z
– volume: 4
  start-page: 68
  issue: 1
  year: 2015
  ident: 1085_CR43
  publication-title: Clin Transl Med
  doi: 10.1186/s40169-015-0068-z
– volume: 6
  start-page: e16384
  issue: 2
  year: 2011
  ident: 1085_CR37
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016384
– volume: 11
  start-page: 181
  year: 2013
  ident: 1085_CR53
  publication-title: BMC Med
  doi: 10.1186/1741-7015-11-181
– volume: 43
  start-page: e47
  issue: 7
  year: 2015
  ident: 1085_CR28
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv007
– volume: 57
  start-page: 289
  year: 1995
  ident: 1085_CR35
  publication-title: J R Stat Soc Ser B Methodol
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 58
  start-page: 389
  issue: 7
  year: 2006
  ident: 1085_CR41
  publication-title: IUBMB Life
  doi: 10.1080/15216540600756004
– volume: 48
  start-page: 992
  issue: 5
  year: 2018
  ident: 1085_CR49
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.04.022
– volume: 157
  start-page: 1498
  issue: 5 Pt 1
  year: 1998
  ident: 1085_CR4
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.157.5.9711044
– volume: 7
  start-page: 335
  issue: 5
  year: 2010
  ident: 1085_CR21
  publication-title: Nat Methods
  doi: 10.1038/nmeth.f.303
– volume: 111
  start-page: 2247
  issue: 6
  year: 2014
  ident: 1085_CR48
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1322269111
– volume: 116
  start-page: 40
  issue: 1
  year: 1999
  ident: 1085_CR2
  publication-title: Chest
  doi: 10.1378/chest.116.1.40
– volume-title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  year: 2017
  ident: 1085_CR46
– volume: 7
  start-page: e47305
  issue: 10
  year: 2012
  ident: 1085_CR6
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0047305
– volume: 384
  start-page: 691
  issue: 9944
  year: 2014
  ident: 1085_CR13
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61136-3
– volume: 83
  start-page: 36
  issue: 1
  year: 2012
  ident: 1085_CR20
  publication-title: Respiration
  doi: 10.1159/000330667
– volume: 11
  start-page: 785
  issue: 3
  year: 2018
  ident: 1085_CR50
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2017.75
– volume: 33
  start-page: 1101
  issue: 7
  year: 2014
  ident: 1085_CR10
  publication-title: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
  doi: 10.1007/s10096-013-2044-0
– volume: 13
  start-page: 52
  year: 2012
  ident: 1085_CR23
  publication-title: BMC Bioinf
  doi: 10.1186/1471-2105-13-52
– volume: 73
  start-page: 422
  issue: 5
  year: 2018
  ident: 1085_CR12
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2017-210408
– volume: 70
  start-page: 809
  issue: 7
  year: 2015
  ident: 1085_CR24
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glu121
– volume: 102
  start-page: 15545
  issue: 43
  year: 2005
  ident: 1085_CR33
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0506580102
– volume: 294
  start-page: L955
  issue: 5
  year: 2008
  ident: 1085_CR40
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00449.2007
– volume: 81
  start-page: 14
  issue: 3
  year: 2014
  ident: 1085_CR16
  publication-title: J Am Coll Dent
– volume: 73
  start-page: 331
  issue: 4
  year: 2017
  ident: 1085_CR11
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2017-210741
– volume: 185
  start-page: 1073
  issue: 10
  year: 2012
  ident: 1085_CR7
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201111-2075OC
– volume: 6
  start-page: e112
  issue: 12
  year: 2017
  ident: 1085_CR51
  publication-title: Emerg Microbes Infect
– volume: 117
  start-page: 398S
  issue: 5 Suppl 2
  year: 2000
  ident: 1085_CR19
  publication-title: Chest
  doi: 10.1378/chest.117.5_suppl_2.398S
– volume: 8
  start-page: e79353
  issue: 11
  year: 2013
  ident: 1085_CR47
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0079353
– volume: 5
  start-page: e8578
  issue: 1
  year: 2010
  ident: 1085_CR5
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008578
– volume: 188
  start-page: 1224
  issue: 10
  year: 2013
  ident: 1085_CR36
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201302-0341OC
– volume: 192
  start-page: 438
  issue: 4
  year: 2015
  ident: 1085_CR14
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201502-0223OC
– volume: 112
  start-page: 7153
  issue: 23
  year: 2015
  ident: 1085_CR26
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1507719112
– volume: 26
  start-page: 139
  issue: 1
  year: 2010
  ident: 1085_CR27
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp616
– volume: 38
  start-page: 500
  issue: 5
  year: 2006
  ident: 1085_CR34
  publication-title: Nat Genet
  doi: 10.1038/ng0506-500
– volume: 14
  start-page: 336
  issue: 2
  year: 2001
  ident: 1085_CR45
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.14.2.336-363.2001
– volume: 47
  start-page: 1082
  issue: 4
  year: 2016
  ident: 1085_CR54
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01406-2015
– volume: 11
  start-page: 32
  issue: 1
  year: 2014
  ident: 1085_CR25
  publication-title: Clin Proteomics
  doi: 10.1186/1559-0275-11-32
– volume: 52
  start-page: 2813
  issue: 8
  year: 2014
  ident: 1085_CR8
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00035-14
– volume: 108
  start-page: 43S
  issue: 2
  year: 1995
  ident: 1085_CR1
  publication-title: Chest
  doi: 10.1378/chest.108.2_Supplement.43S
– volume-title: Lung microbiome dynamics in chronic obstructive pulmonary disease exacerbations. The European respiratory journal
  year: 2016
  ident: 1085_CR9
– volume: 195
  start-page: 1640
  issue: 12
  year: 2017
  ident: 1085_CR15
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201607-1408OC
– volume: 16
  start-page: 67
  year: 2015
  ident: 1085_CR29
  publication-title: Genome Biol
  doi: 10.1186/s13059-015-0637-x
– volume: 47
  start-page: 45
  issue: 1
  year: 2001
  ident: 1085_CR17
  publication-title: J Postgrad Med
– volume: 14
  start-page: 85
  year: 2013
  ident: 1085_CR44
  publication-title: Respir Res
  doi: 10.1186/1465-9921-14-85
– volume: 8
  start-page: e68302
  issue: 7
  year: 2013
  ident: 1085_CR39
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0068302
– volume-title: lmerTest: tests in linear mixed effects models
  year: 2014
  ident: 1085_CR31
– volume: 6
  start-page: e24457
  issue: 9
  year: 2011
  ident: 1085_CR32
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0024457
– volume: 67
  start-page: 1
  issue: 1
  year: 2015
  ident: 1085_CR30
  publication-title: J Stat Softw
  doi: 10.18637/jss.v067.i01
– volume: 6
  start-page: 209
  issue: 1
  year: 2009
  ident: 1085_CR52
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph6010209
– volume: 184
  start-page: 662
  issue: 6
  year: 2011
  ident: 1085_CR55
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201104-0597OC
SSID ssj0017875
Score 2.539136
Snippet Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We...
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a...
Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We...
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a...
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).BACKGROUNDLittle is known...
Abstract Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD)....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 113
SubjectTerms Aged
Antibiotics
Bacterial infections
Care and treatment
Cell adhesion & migration
Chronic obstructive lung disease
Chronic obstructive pulmonary disease
Clinical study
COPD
Cytokines
Development and progression
Dysbacteriosis
Exacerbations
Female
Gene expression
Gene Expression Profiling - methods
Haemophilus
Haemophilus influenzae - genetics
Health aspects
Health care
Host Microbial Interactions - physiology
Host-bacteria relationships
Humans
Immune response
Immune system
Infectious diseases
Inflammation
Interferon
Leukocytes (neutrophilic)
Longitudinal Studies
Lung - microbiology
Lung - physiology
Lung diseases
Male
Medicine
Medicine & Public Health
Microbiome
Microbiomes
Microbiota (Symbiotic organisms)
Microbiota - physiology
Middle Aged
Moraxella
Moraxella - genetics
Neutrophilia
Obstructive lung disease
Pneumology/Respiratory System
Proteomes
Pulmonary Disease, Chronic Obstructive - genetics
Pulmonary Disease, Chronic Obstructive - microbiology
Relative abundance
Respiratory tract
rRNA 16S
Signal transduction
Signaling
Smoking
Sputum
Sputum - microbiology
Sputum - physiology
Streptococcus infections
Transcriptome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals (WRLC)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEB-kD-KLqPVjtcoWBEFZutlNssnjKZYirU8W-hbytXjQ7pW7Vmn_emeyubNbqb74cA93Sbhk9jeZmZ3MLwBvewwqoqIgh_UYoDQSdU4FUTFr6RK7TvuG6p2PvsqDY_7lRJzcuOqLzoSN9MCj4Pa8YBYxoqJVPW8c_qelYkkqiLS161Mdea3rdTCV8wcIQ5FzmEzJvRVZNQqbdZVO219PrFAi6_9zS75hk26fl7yVNE22aP8RPMxOZDkbJ_8Y7sXhCdw_ymnybTiczZc_7VVJFRzV2XzkWjqLJXFDLMdKhhV-Kf3IjFsuXKaR_RHL88tTRKZdXpU5d_MUjvc_f_t0UOVrEyov6_ai8m3TcosfjKQEd4GJwKNH065DRGdQtDoGoZ3gUWN42ocORdoHHTocyBkatWewNSyG-ALKzln0D31ULkVSQfWCS9vX0gkWGWsLqNdiND5zitPVFqcmxRZKmlHyBiVPVKTCXBfwfjPkfCTU-Fvnj_RsNh2JCzv9gAgxGSHmXwgp4B09WUMai5PzNhce4BKJ-8rMhMZ9Ds1yU8DOpCdqmp82r7FhsqavDLpADe6a6OcVsLtpppF0em2Ii0vs07aMXMuOFfB8hNJmSS1d_aOVLKCbgGyy5mnLMP-eeMClEKLjqoAPazj-ntadIn35P0T6Ch40pEz0NkruwBZiNL5G5-zCvUl6-Asi9zTG
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6NISFeEL_JGChISEigQJ3Yjv2AUEFME6I8UWlvlu04o1KXjnQbdH89d4nbkTH20IfUdhRfvvPdxb7vAF7WGFQERUEOqzFAySXqnKpExqylInal9jnlO0--yf0p_3IgDrZgXd4qCnB5ZWhH9aSm7fzt75-rD6jw7zuFV_LdkmwWBcU6687Sn9-Am2iYJMViE36xqYDYFH2ykci0zlnc5LzyFgMz1bH5_7tm_2W0Lh-ovLSr2hmrvbtwJ3qZ6biHxT3YCs19uDWJ--gP4Ot41v6yq5RSPLKjWU_GdBRSIo9o-1SHJV6kvqfOTRcu8syehfT4dI7Qte0qjZs7D2G69_n7p_0s1lXIvBwVJ5kv8oJb_GGoJbirmKh48Gj7dRXQWxSFDpXQTvCgMX6tq9IFW1e6KnEgZ2j1HsF2s2jCE0hLZ9GB9EG5LtSqVC24tPVIOsECY0UCo7UYjY-k41T7Ym664ENJ00veoOSJq1SY8wReb4Yc94wb13X-SO9m05HIsrs_Fu2hibpnvGAWlxkVrKp57hC2lvJtKafWjlxdJvCK3qwhkOHDeRszE3CKRI5lxkLjQoh2O09gd9ATVdEPm9fYMGskG_SRclxW0RFM4MWmmUbS8bYmLE6xT1Ew8j1LlsDjHkqbKRVUG0grmUA5ANlgzsOWZvajIwqXQoiSqwTerOF48Vj_FenO9ZN4CrdzUhP6ECV3YRvRF56hX3binnfa9gdGwjEO
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB-0gvgifru1ygqCoCxeNpts8ngWSxHrk4W-hXwtHrR75a5V2r--M9nc2q0f4MM-3GYCm-Q3mZmbzC8AbzoMKqKiIId1GKDUEnVOBVExa-kSu1b7muqdD77K_cPm85E4ymTRVAtzPX_PlPywJntEAa-u0jn5y9twRzAuU15W7o4JA8SdyEnLP3abmJ3Ezv_7HnzNCN08IHkjS5qMz94DuJ-9xnI-LPNDuBX7R3D3IOfFH8OX-WL1016UVLJRnSwGcqWTWBIZxGooXVjjj9IPVLjl0mXe2B-xPD0_Rija1UWZkzVP4HDv07fd_Srfk1B5OeNnlec1byw-GDqJxgUmQhM92nIdInp_gusYhHaiiRrj0S60Ltou6NBix4ahFXsKW_2yj8-hbJ1Fh9BH5VLoFFQnGmm7mXSCRcZ4AbPNNBqfScTpLotjk4IJJc0w8wZnnrhHhbks4N3Y5XRg0PiX8Edam1GQyK_TC8SEybpkvGAWtw0Vreqa2iEMLdXPUo2snbmuLeAtrawhFcWP8zZXGuAQiezKzIXGjQ3tcF3AzkQSVctPmzfYMFm11wZ9nhq3SXTsCng9NlNPOq7Wx-U5ynDOyJdsWQHPBiiNQ-J0149WsoB2ArLJmKct_eJ7Iv6WQoi2UQW838Dx12f9dUq3_0v6BdyrSWvofya5A1sIxvgS3a4z9yop3BUeDiTs
  priority: 102
  providerName: Springer Nature
Title Airway host-microbiome interactions in chronic obstructive pulmonary disease
URI https://link.springer.com/article/10.1186/s12931-019-1085-z
https://www.ncbi.nlm.nih.gov/pubmed/31170986
https://www.proquest.com/docview/2242703399
https://www.proquest.com/docview/2331256071
https://pubmed.ncbi.nlm.nih.gov/PMC6555748
https://doaj.org/article/c51a6388ea8f42bebea01184343a0bf7
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3_a9QwFH_oBuIv4ner86ggCErZpW3S5Ce5HRtDvaHi4H4LaZrqwdaed5uy_fW-l-Y6O3E_tNAmgSb9vLz3krzPA3hdo1PhJDk5rEYHJRUoc7LiCTOGktgVyqYU7zw7EofH-Yc5n4cFt3U4VrmZE_1EXbWW1sh3UdWkiE7Up--XPxPKGkW7qyGFxm3Y9tRliOdi3jtcDMHIu-giniiVsrCryaTYXZOeI0daJf78_eVAL3n6_n8n6b-01PUTlNe2Ub12OrgP94JZGU86HDyAW655CHdmYeP8EXyaLFa_zUVMMR3J6aJjXzp1MbFFrLrYhjU-xLbjyo3bMhDL_nLx8vwEO29WF3HYzXkMxwf736aHSUikkFgxzs4Sm6VZbvBC34rnZcV4lTuLyl5VDs1DnilXcVXy3Cl0WOuqKJ2pK1UV2DBnqOaewFbTNu4ZxEVp0GK0Tpbet6pkzXNh6rEoOXOMZRGMN8OobWAZp2QXJ9p7G1LobuQ1jjyRk3J9GcHbvsmyo9i4qfIe_Zu-IrFj-xft6rsOwqYtZwbnFemMrPO0RJwaCrClIFozLusigjf0ZzXJMH6cNSEUAbtIbFh6whXOfKio0wh2BjVR9uyweIMNHWR_ra-QGsGrvpha0nm2xrXnWCfLGBmbBYvgaQelvksZJQNSUkRQDEA26POwpFn88MzggnNe5DKCdxs4Xn3Wf4f0-c2deAF3UxITWnkSO7CF6HMv0RA7K0de2kawvbd_9PkrPk3FdOQXNfD-8YvE-yyXfwB5-zME
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kDAgSCAkUrU7iJH5AqINNHWsrhDZpb57jOKzSlpR2Y-r-KP5G7hInI0PsbQ99aG1X8fk-c77fAbzJMagwCQU5LMcAxY9Q5pKMe0wpamIXC-1TvfN4Eg33w68H_GAFfje1MHStstGJlaLOSk3vyDfQ1PjInWhPP81-etQ1irKrTQuNmi12zfIcQ7bFx50veL5vfX97a-_z0LNdBTwd9YNTTwd-ECr8YKDBwzRjPAuNRssnMoO-Eg-EybhIeWgERm95FqdG5ZnIYlwYMtT5-L-3YDWkitYerG5uTb59b_MWyP68rmfinhA-s3lUlkQbC7KsFLoLr7rxf9GxhFXDgH_Nwl928eqdzSuJ28oebt-He9aRdQc15z2AFVM8hNtjm6p_BKPBdH6uli5VkXgn0xrv6cS4hE8xr6spFvjF1TU6r1umFsr2l3FnZ8dIbjVfujZ_9Bj2b4TIT6BXlIV5Bm6cKvRRtUnSKprLkpyHkcr7UcqZYSxwoN-QUWqLa07tNY5lFd8kkawpL5HyBIfK5YUD79slsxrU47rJm3Q27UTC465-KOc_pBVvqTlTqMkSo5I89FOUDEUlvVS2q_ppHjvwjk5WktbAh9PKFj_gFgl_Sw64QF2LroHvwHpnJkq77g43vCGttlnIS9lw4HU7TCvpBl1hyjOcEwSM3NuYOfC0ZqV2SwG1HxJJ5EDcYbLOnrsjxfSowiKPOOdxmDjwoWHHy8f6L0nXrt_EK7gz3BuP5Ghnsvsc7vokMvTeK1qHHnKieYFu4Gn60sqeC4c3Le5_AAuBa0I
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB-0QvFF_DZaNYIgKKG3ye5m83hWj6pt8cFC35b9Sj1oc8fdtaX9651J9qKpH-BDHpKdhf2Y2ZnJ7PwG4HWNTkVQ5OSwGh2UXKLMKS8yZgwVsSsrl1O-8_6B3D3kn4_EUaxzulzfdl-HJLucBkJpalbbc193Iq7k9pK0FLnBVdbenr-6Cbc4aT6K1sqdPoyA3ChiKPOP3QbKqMXs__1k_kU1Xb82eS122qqkyV24E23JdNxt_j24EZr7sLkfo-UPYG88XVyYy5QSObLTaQe5dBpSgohYdAkNS3xJXQeQm85sRJM9D-n87AQZ1Cwu0xjCeQiHk4_fdnazWD0hc3JUrDJX5AU3-KBDJbj1THgeHGr4yge0CUVRBS8qK3io0EutfWmDqX3lS-zIGeq2R7DRzJrwBNLSGjQTXVC2dai8qgWXph5JK1hgrEhgtF5G7SK0OFW4ONGti6Gk7lZe48oTIqnQVwm87bvMO1yNfxG_p73pCQkSu_0wWxzrKGHaCWbwMFHBqJrnFpnTUFYtZc6aka3LBN7QzmoSXBycMzH_AKdIEFh6LCo87lA75wlsDShR4Nywec0bOgr8UqMllOPhieZeAq_6ZupJl9iaMDtDmqJgZGGWLIHHHSv1UyqoAlClZALlgMkGcx62NNPvLRy4FEKUXCXwbs2OP4f11yV9-l_UL2Hz64eJ3vt08OUZ3M5JgOhHlNyCDeTL8BztspV90creDzInMCA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Airway+host-microbiome+interactions+in+chronic+obstructive+pulmonary+disease&rft.jtitle=Respiratory+research&rft.au=Zhang%2C+Wangrbara+Maschera&rft.au=Lea%2C+Simon&rft.au=Kolsum%2C+Umme&rft.au=Michalovich%2C+David&rft.date=2019-06-06&rft.pub=BioMed+Central&rft.issn=1465-9921&rft.eissn=1465-993X&rft.volume=20&rft_id=info:doi/10.1186%2Fs12931-019-1085-z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon